Search results for Kyowa Hakko

KYORIN Pharmaceutical Co., Ltd. 2026 Q4 - Results - Earnings Call Presentation

Eisai Co., Ltd. 2026 Q4 - Results - Earnings Call Presentation

Suntory Holdings to buy Daiichi Sankyo's OTC unit to expand health business

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing

Molmir, Developer of Drug Discovery Platform Technology to Visualize “Molecular Movement,” Raises ¥300 Million in Series...

Molmir, which possesses a unique drug discovery platform technology to visualize “molecular movement,” announced on the 22nd that it has raised ¥300 million in a Series A round. Th...

Japanese Pharma Companies Turning to CDMOs Earlier in Product Life Cycle

The bottleneck isn’t discovery anymore. It’s execution. In peptides, programs are running into challenges around analytical complexity, scaleup, and the availability of key raw mat...

Kyoto University to seek 5-year extension of iPS cell patent

Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare - Slideshow

Chiesi Group Grows Again in Rare Disease With $1.9B KalVista Acquisition

KalVista Pharmaceuticals brings to Chiesi Group the product Ekterly, the first FDA-approved oral drug for acute treatment of swelling attacks from the rare disease hereditary angio...

Novelty Nobility Expands AGC Biologics Deal to Take Product Candidate Through GMP Manufacturing

The project leverages AGC Biologics’ global network, having completed cell line development in Copenhagen, Denmark, to be followed by tech transfer to Chiba, Japan, for the next ma...

Beigene

Beigene Anonymous (not verified) Mon, 05/25/2026 - 11:38 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...

<![CDATA[Haisco Enters $745 Million Exclusive License Agreement with AbbVie ]]>

Samsung Bioepis launches Ustekinumab biosimilar in Japan with Nipro

Samsung Bioepis announced Wednesday the launch of its Ustekinumab biosimilar in Japan, marking the company’s first product debut in the country under a partnership with NIPRO Corp....

Ajinomoto Foods North America The St James bring athlete well being to life

At a time when athletes are balancing increasingly demanding training schedules with everyday life Ajinomoto Co Inc and its subsidiary Ajinomoto Foods North America announced a new...

<![CDATA[Shionogi Enters $2.5 Billion Agreement to Acquire All Rights to Radicava]]>

<![CDATA[FDA Extends Priority Review of Leqembi Iqlik Subcutaneous Injection ]]>

Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody

CHENGDU, China, May 12, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that it has received a clinical...

Metaphore Biotechnologies, Developer of Functional Antibody AI Drug Discovery Platform, Receives Investment from TOHO Ho...

On the 6th, TOHO Ventures, operated by Global Brain, announced that it has executed an investment in Metaphore Biotechnologies, a company developing an AI platform to accelerate th...

三菱ケミカル、基礎化学品事業を分社化へ　他社との再編を視野に

Kiniksa

Kiniksa Anonymous (not verified) Tue, 05/19/2026 - 08:34 field_thread_url https://cafepharma.com/boards/threads/kiniksa.658756/ board na...

Beigene

Beigene Anonymous (not verified) Thu, 04/30/2026 - 14:18 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...

抗体に何度も働ける機能を付与　少量でも効果持続、自宅投与を可能に

Sang

Sang Anonymous (not verified) Thu, 05/07/2026 - 02:21 field_thread_url https://cafepharma.com/boards/threads/sang.673523/ board name...